Windlas Biotech Limited (WINDLAS)
₹885.3
INR+28.30(+3.30%)
As of March 4, 2025 9:52:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹1785.93 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹1401.17 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
29.16
Forward P/E
Price to Earnings ratio based on forecasted earnings
NA
PEG Ratio
Price/Earnings to Growth ratio
0.69
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
2.45
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
38.04%
Operating Margin
Operating income as a percentage of revenue
9.07%
Return on Equity
Net income as a percentage of shareholders' equity
12.93%
Revenue (TTM)
Total revenue over trailing 12 months
₹728.46 Cr+20.200000000000003%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹108.08 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹29.30+3.2%
Balance Sheet
Total Cash
Total cash and short-term investments
₹213.02 Cr
Total Debt
Total short-term and long-term debt
₹18.95 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
4.02%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹474.1 - ₹1198.25
Beta
Measure of stock's volatility compared to the market
0.36
Shares Outstanding
Total number of shares issued by the company
₹2.08 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
2.47%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
0.62%
Payout Ratio
Percentage of earnings paid as dividends
18.78%